25.06.2024
Publications category: Program strategies and efficiencies
25.06.2024
Absorption, Bioavailability, and Immunogenicity after Subcutaneous Administration: Evaluation of a Subcutaneous Platform within the Open Systems Pharmacology framework
23.08.2023
Predicting Reductions in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations from FEV1 – A Model-Based Meta-Analysis of Literature Data from Controlled Randomized Clinical Trials
23.08.2023
Towards Industrialisation of Probability of Pharmacological Success (PoPS)
23.08.2023
Translating Pharmacometrics to a Pharmacoeconomic Model of COPD
14.06.2023
How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example
14.06.2023
Physiological Based Pharmacokinetic and Biopharmaceutics Modelling of Subcutaneously Administered Compounds – An Overview of In Silico Models
14.06.2023
Overview of Authorized Drug Products for Subcutaneous Administration: Pharmaceutical, Therapeutic, and Physicochemical Properties
14.06.2023
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary Report
14.06.2023
Assessment of Expected Drug Exposure Relative Maximum Safety Limits in Early Phase Studies
14.06.2023